Sema4 to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021

Rhea-AI Summary

Sema4 (SMFR), a health intelligence company focused on AI and machine learning, will announce its second quarter 2021 financial results on August 16, 2021, after market close. The management, including CEO Eric Schadt and CFO Isaac Ro, will host a conference call at 4:30 p.m. ET to discuss these results. Investors can access the live call by dialing specific numbers or through a webcast on the Sema4 investor relations website. Sema4 aims to revolutionize healthcare with its Centrellis health intelligence platform, emphasizing patient partnership and data sharing for better health outcomes.

Positive

• Scheduled release of Q2 2021 financial results may indicate ongoing business progress.
• Focus on advancing healthcare through AI and machine learning reflects innovation potential.

Negative

• None.

STAMFORD, Conn., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced it will release financial results for the second quarter of 2021 after the market close on Monday, August 16, 2021. On the same day, Eric Schadt, Ph.D., Founder and Chief Executive Officer of Sema4, and Isaac Ro, Chief Financial Officer of Sema4, will host a conference call to discuss financial and operating results at 4:30 p.m. ET.

Conference Call Details
The conference call will begin at 4:30 p.m. Eastern Time on Monday, August 16, 2021. Interested parties may access the live teleconference by dialing (844) 631-4065 for domestic callers or (929) 517-0920 for international callers, followed by conference ID: 6887762. A live and archived webcast of the event will be available on the “Events” section of the Sema4 investor relations website at https://ir.sema4.com/.

About Sema4
Sema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. Centrellis™, our innovative health intelligence platform, is enabling us to generate a more complete understanding of disease and wellness and to provide science-driven solutions to the most pressing medical needs. Sema4 believes that patients should be treated as partners, and that data should be shared for the benefit of all.

For more information, please visit sema4.com and connect with Sema4 on Twitter, LinkedIn, Facebook and YouTube.

Investor Relations Contact:
David Deuchler
Gilmartin Group
investors@sema4.com

Media Contact:
Radley Moss
radley.moss@sema4.com

 

FAQ

When will Sema4 release its Q2 2021 financial results?

Sema4 will release its Q2 2021 financial results on August 16, 2021, after market close.

What time is the Sema4 conference call for Q2 2021 results?

The conference call to discuss Sema4's Q2 2021 results will begin at 4:30 p.m. ET on August 16, 2021.

How can I listen to the Sema4 conference call?

Interested parties can access Sema4's conference call by dialing (844) 631-4065 for domestic calls or (929) 517-0920 for international calls, using conference ID: 6887762.

What is Sema4's focus in the healthcare industry?

Sema4 is dedicated to advancing healthcare through data-driven insights and aims to transform healthcare using AI and machine learning.